{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:29:57Z","timestamp":1782253797386,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s13353-014-0254-5","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T09:46:21Z","timestamp":1415007981000},"page":"193-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mutational analysis of BRCA1\/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1\/2 alterations detected by next generation sequencing"],"prefix":"10.1007","volume":"56","author":[{"given":"Magdalena","family":"Ratajska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Krygier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Stukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Ku\u017aniacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Koczkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Dudziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"\u015aniadecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"D\u0119bniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Wydra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Brozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Biernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ake","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Limon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Was\u0105g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"254_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","volume":"376","author":"MW Audeh","year":"2010","unstructured":"Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, Scott C, Weitzel JN, Oaknin A, Loman N, Lu K, Schmutzler RK, Matulonis U, Wickens M, Tutt A (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 376:245\u2013251. doi: 10.1016\/s0140-6736(10)60893-8","journal-title":"Lancet"},{"key":"254_CR2","first-page":"2433","volume":"4","author":"A Berchuck","year":"1998","unstructured":"Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, Deffenbaugh AM, Miron A, Marks JR, Futreal PA, Frank TS (1998) Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 4:2433\u20132437","journal-title":"Clin Cancer Res"},{"key":"254_CR3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2007.09.035","volume":"108","author":"I Brozek","year":"2008","unstructured":"Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M, Stukan M, Emerich J, Limon J (2008) High frequency of BRCA1\/2 germline mutations in consecutive ovarian cancer patients in Poland. Gynecol Oncol 108:433\u2013437. doi: 10.1016\/j.ygyno.2007.09.035","journal-title":"Gynecol Oncol"},{"key":"254_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13353-011-0040-6","volume":"52","author":"I Brozek","year":"2011","unstructured":"Brozek I, Cybulska C, Ratajska M, Piatkowska M, Kluska A, Balabas A, Dabrowska M, Nowakowska D, Niwinska A, Pamula-Pilat J, Tecza K, Pekala W, Rembowska J, Nowicka K, Mosor M, Januszkiewicz-Lewandowska D, Rachtan J, Grzybowska E, Nowak J, Steffen J, Limon J (2011) Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet 52:325\u2013330. doi: 10.1007\/s13353-011-0040-6","journal-title":"J Appl Genet"},{"key":"254_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10689-012-9519-5","volume":"11","author":"I Brozek","year":"2012","unstructured":"Brozek I, Ratajska M, Piatkowska M, Kluska A, Balabas A, Dabrowska M, Nowakowska D, Niwinska A, Rachtan J, Steffen J, Limon J (2012) Limited significance of family history for presence of BRCA1 gene mutation in polish breast and ovarian cancer cases. Fam Cancer 11:351\u2013354. doi: 10.1007\/s10689-012-9519-5","journal-title":"Fam Cancer"},{"key":"254_CR6","doi-asserted-by":"crossref","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913\u2013917. doi: 10.1038\/nature05789","DOI":"10.1038\/nature05789"},{"key":"254_CR7","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1093\/nar\/gkg761","volume":"31","author":"SF El-Khamisy","year":"2003","unstructured":"El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW (2003) A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res 31:5526\u20135533. doi: 10.1093\/nar\/gkg761","journal-title":"Nucleic Acids Res"},{"key":"254_CR8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917\u2013921. doi: 10.1038\/nature03445","journal-title":"Nature"},{"key":"254_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O\u2019Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS (2009) Inhibition of poly(ADP-Ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361:123\u2013134. doi: 10.1056\/NEJMoa0900212","journal-title":"N Engl J Med"},{"key":"254_CR10","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2009.26.9589","volume":"28","author":"PC Fong","year":"2010","unstructured":"Fong PC, Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, De Greve J, Lubinski J, Shanley S, Messiou C, A\u2019Hern R, Tutt A, Ashworth A, Stone J, Carmichael J, Schellens JH, de Bono JS, Kaye SB (2010) Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J Clin Oncol 28:2512\u20132519. doi: 10.1200\/jco.2009.26.9589","journal-title":"J Clin Oncol"},{"key":"254_CR11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10689-012-9560-4","volume":"11","author":"P Gaj","year":"2012","unstructured":"Gaj P, Kluska A, Nowakowska D, Balabas A, Piatkowska M, Dabrowska M, Niwinska A, Ostrowski J (2012) High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer. Fam Cancer 11:623\u2013628. doi: 10.1007\/s10689-012-9560-4","journal-title":"Fam Cancer"},{"key":"254_CR12","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1086\/302922","volume":"66","author":"B Gorski","year":"2000","unstructured":"Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubinski J (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963\u20131968. doi: 10.1086\/302922","journal-title":"Am J Hum Genet"},{"key":"254_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ijc.20162","volume":"110","author":"B Gorski","year":"2004","unstructured":"Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683\u2013686. doi: 10.1002\/ijc.20162","journal-title":"Int J Cancer"},{"key":"254_CR14","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/carcin\/bgt272","volume":"34","author":"M Infante","year":"2013","unstructured":"Infante M, Duran M, Acedo A, Sanchez-Tapia EM, Diez-Gomez B, Barroso A, Garcia-Gonzalez M, Feliubadalo L, Lasa A, de la Hoya M, Esteban-Cardenosa E, Diez O, Martinez-Bouzas C, Godino J, Teule A, Osorio A, Lastra E, Gonzalez-Sarmiento R, Miner C, Velasco EA (2013) The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins. Carcinogenesis 34:2505\u20132511. doi: 10.1093\/carcin\/bgt272","journal-title":"Carcinogenesis"},{"key":"254_CR15","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa1105535","volume":"366","author":"J Ledermann","year":"2012","unstructured":"Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Macpherson E, Watkins C, Carmichael J, Matulonis U (2012) Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med 366:1382\u20131392. doi: 10.1056\/NEJMoa1105535","journal-title":"N Engl J Med"},{"key":"254_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(14)70228-1","volume":"15","author":"J Ledermann","year":"2014","unstructured":"Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott CL, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Spencer S, Dougherty B, Orr M, Hodgson D, Barrett JC, Matulonis U (2014) Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol 15:852\u2013861. doi: 10.1016\/s1470-2045(14)70228-1","journal-title":"Lancet Oncol"},{"key":"254_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0968-0004(00)89089-1","volume":"20","author":"T Lindahl","year":"1995","unstructured":"Lindahl T, Satoh MS, Poirier GG, Klungland A (1995) Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20:405\u2013411. doi: 10.1016\/s0968-0004(00)89089-1","journal-title":"Trends Biochem Sci"},{"key":"254_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-006-9182-3","volume":"99","author":"J Lubinski","year":"2006","unstructured":"Lubinski J, Gorski B, Huzarski T, Byrski T, Gronwald J, Serrano-Fernandez P, Domagala W, Chosia M, Ucinski M, Grzybowska E, Lange D, Maka B, Mackiewicz A, Karczewska A, Breborowicz J, Lamperska K, Stawicka M, Gozdecka-Grodecka S, Bebenek M, Sorokin D, Wojnar A, Haus O, Sir J, Mierzwa T, Niepsuj S, Gugala K, Gozdz S, Sygut J, Kozak-Klonowska B, Musiatowicz B, Posmyk M, Kordek R, Morawiec M, Zambrano O, Wasko B, Fudali L, Skret J, Surdyka D, Urbanski K, Mitus J, Rys J, Szwiec M, Rozmiarek A, Dziuba I, Wandzel P, Wisniowski R, Szczylik C, Kozak A, Kozlowski W, Narod SA (2006) BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat 99:71\u201376. doi: 10.1007\/s10549-006-9182-3","journal-title":"Breast Cancer Res Treat"},{"key":"254_CR19","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cncr.21276","volume":"104","author":"EJ Majdak","year":"2005","unstructured":"Majdak EJ, Debniak J, Milczek T, Cornelisse CJ, Devilee P, Emerich J, Jassem J, De Bock GH (2005) Prognostic impact of BRCA1 pathogenic and BRCA1\/BRCA2 unclassified variant mutations in patients with ovarian carcinoma. Cancer 104:1004\u20131012. doi: 10.1002\/cncr.21276","journal-title":"Cancer"},{"key":"254_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejca.2003.09.016","volume":"40","author":"S Malander","year":"2004","unstructured":"Malander S, Ridderheim M, Masback A, Loman N, Kristoffersson U, Olsson H, Nilbert M, Borg A (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in southern Sweden. Eur J Cancer 40:422\u2013428. doi: 10.1016\/j.ejca.2003.09.016","journal-title":"Eur J Cancer"},{"key":"254_CR21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ijc.11338","volume":"106","author":"J Menkiszak","year":"2003","unstructured":"Menkiszak J, Gronwald J, Gorski B, Jakubowska A, Huzarski T, Byrski T, Foszczynska-Kloda M, Haus O, Janiszewska H, Perkowska M, Brozek I, Grzybowska E, Zientek H, Gozdz S, Kozak-Klonowska B, Urbanski K, Miturski R, Kowalczyk J, Pluzanska A, Niepsuj S, Koc J, Szwiec M, Drosik K, Mackiewicz A, Lamperska K, Strozyk E, Godlewski D, Stawicka M, Wasko B, Bebenek M, Rozmiarek A, Rzepka-Gorska I, Narod SA, Lubinski J (2003) Hereditary ovarian cancer in Poland. Int J Cancer 106:942\u2013945. doi: 10.1002\/ijc.11338","journal-title":"Int J Cancer"},{"key":"254_CR22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuckeidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugenstrano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannonalbright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371. doi: 10.1126\/science.7545954","journal-title":"Science"},{"key":"254_CR23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/humu.9139","volume":"21","author":"M Perkowska","year":"2003","unstructured":"Perkowska M, Brozek I, Wysocka B, Haraldsson K, Sandberg T, Johansson U, Sellberg G, Borg A, Limon J (2003) BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland. Hum Mutat 21:553\u2013554. doi: 10.1002\/humu.9139","journal-title":"Hum Mutat"},{"key":"254_CR24","first-page":"263","volume":"19","author":"M Ratajska","year":"2008","unstructured":"Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, Limon J (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in northern Poland. Oncol Rep 19:263\u2013268. doi: 10.3892\/or.19.1.263","journal-title":"Oncol Rep"},{"key":"254_CR25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700\u2013710. doi: 10.1086\/318787","journal-title":"Am J Hum Genet"},{"key":"254_CR26","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1007\/s11033-013-2775-0","volume":"40","author":"H Rudnicka","year":"2013","unstructured":"Rudnicka H, Debniak T, Cybulski C, Huzarski T, Gronwald J, Lubinski J, Gorski B (2013) Large BRCA1 and BRCA2 genomic rearrangements in polish high-risk breast and ovarian cancer families. Mol Biol Rep 40:6619\u20136623. doi: 10.1007\/s11033-013-2775-0","journal-title":"Mol Biol Rep"},{"key":"254_CR27","doi-asserted-by":"crossref","unstructured":"Statement of the American Society of Clinical Oncology (1996) Genetic testing for cancer suscepti bility, adopted on February 20, 1996. J Clin Oncol 14(5):1730\u20131736, discussion 1737\u201340","DOI":"10.1200\/JCO.1996.14.5.1730"},{"key":"254_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y","volume":"16","author":"C Szabo","year":"2000","unstructured":"Szabo C, Masiello A, Ryan JF, Brody LC (2000) The breast cancer information core: database design, structure, and scope. Hum Mutat 16:123\u2013131. doi: 10.1002\/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y","journal-title":"Hum Mutat"},{"key":"254_CR29","author":"M Szwiec","year":"2014","unstructured":"Szwiec M, Jakubowska A, Gorski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, Debniak T, Byrski T, Kluzniak W, Wokolorczyk D, Birkenfeld B, Akbari MR, Narod SA, Lubi\u0144ski J, Cybulski C (2014) Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. Clin Genet. doi: 10.1111\/cge.12360","journal-title":"Clin Genet"},{"key":"254_CR30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G","volume":"15","author":"M Looij van Der","year":"2000","unstructured":"van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and\/or ovarian cancer families from north-eastern Poland. Hum Mutat 15:480\u2013481. doi: 10.1002\/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G","journal-title":"Hum Mutat"},{"key":"254_CR31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rices C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792. doi: 10.1038\/378789a0","journal-title":"Nature"}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-014-0254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13353-014-0254-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-014-0254-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T23:25:58Z","timestamp":1565997958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13353-014-0254-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1007\/s13353-014-0254-5","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,1]]}}}